Glaxosmithkline Share News (GSK)

UK Dividends Calendar - Week Ahead

UK Dividends Calendar - Week Ahead

UK MIDDAY BRIEFING: Standard Chartered Management Get Backed

Ex-divs to take up to 10.1 points off FTSE 100 on Nov. 6

LONDON, Nov 3 (Reuters) - The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no longer qualify for the latest dividend payout. According to Reuters calculations at current market prices, the effect of the resulting adjustment to prices by market-maker

UK MORNING BRIEFING: Discount Airlines Support London Stocks

UK Dividends Calendar - Week Ahead

UK Dividends Calendar - Week Ahead

UPDATE: RBS Into Profit But Sets Aside GBP400 Million For Forex Probe

UK Dividends Calendar - Week Ahead

UK Dividends Calendar - Week Ahead

Canadian Ebola vaccine to be tested in Europe, Gabon, Kenya

LONDON, Oct 29 (Reuters) - Trials of an experimental vaccine developed by the Canadian government and licensed to NewLink Genetics will begin swiftly in healthy volunteers in Europe, Gabon and Kenya, under a programme with funding from the Wellcome Trust. A $5 million grant from the medical

FTSE 100 movers: StanChart slides after third-quarter results disappoint

Shares in banking group Standard Chartered dropped after the company reported a 16% decline in operating profit in the third quarter and said that full-year earnings would be lower than last year. Shares in banking counterpart Standard Chartered dropped after the company reported a 16% decline in op

Swiss test GSK Ebola vaccine in some volunteers going to Africa

GENEVA, Oct 28 (Reuters) - Switzerland's drug regulator said on Tuesday it had approved the testing of an experimental Ebola vaccine from GlaxoSmithKline on healthy volunteers, some of whom will be travelling to West Africa as medical staff. The trial will be conducted among 120 volunteer p

GSK Nigeria 9-month pre-tax profit falls 25.9 pct

LAGOS, Oct 28 (Reuters) - The Nigerian unit of drugmaker GlaxoSmithKline on Tuesday said its 9-month pretax profit fell 25.9 percent to 2.06 billion Nigerian naira($12.47 million), compared with 2.78 billion naira the previous year. Turnover however rose to 23.21 billion naira during the n

Tuesday broker round-up UPDATE

Afren: Credit Suisse lowers target price from 132p to 115p staying with its outperform rating. African Barrick Gold: Westhouse moves target price from 230p to 240p and keeps an add rating. Anglo American: Investec reduces target price from 1603p to 1588p and keeps a buy recommendation. APR Energy: